Pharmaceuticals: State of the Industry Report
The pharmaceutical manufacturing industry is on the brink of a significant shift. New discoveries, treatments, medicines, and even cures, are forcing companies to change how they manage the development and production of pharmaceuticals.
To better understand the trends and challenges the industry is up against, we conducted in-depth global research in developing this report. Among the key findings:
- The Price-Cost Paradox: Pressure is building on all sides, with inflation and demand for lower costs rising. There will be an impact on R&D and investment.
- A New Era of Healthcare: As new advancements in the identification of disease, treatment and even cures continue, companies are learning they need to keep pace with that progress or risk setbacks.
- Companies need to invest to keep pace: new technologies around AI, robotics, automation and predictive analytics create efficiencies while lowering costs.
- Flexibility is key: Companies that adapt flexibility as part of their strategy are better positioned to contain costs, compete in the market and scale manufacturing
- Continuous Manufacturing is leading the way: Moving away from batch manufacturing is providing flexibility and accelerating time to market, and allows for swift response as demands change.
Download the report
Please fill in the form to receive a copy of the report:
